research reports and media, page-2244

It's no surprise that people are doing this currently although I doubt it's too widespread. We have examples on this very forum, and good luck to them. They want a solution now, and who could begrudge them that? In absence of any available injectable format approved for human use here, some people are going to:

1. Get a chemist to make an injectable compound made from mashed-up Elmiron tablets.
2. Get a dodgy vet to slip them some on the side.

Paul has spoken before about how not only could a vet be struck-off for doing this, but that the animal format can be a very different compound, and isn't approved anywhere for human use. Dr Yurth echoes this saying she would be concerned about 'impurities' from the animal version and so prefers to use a compounding chemist to mash-up Elmiron.

As @poolboy states, this practice would no longer be allowed when Zilosul is approved for human use.

From that point, you are left with two choices, Zilosul....or the black market. Zilosul might cost you AU$3k+ (less reimbursements) for a full course of treatment. This could be an annual cost, or if you are like @Happell you might not need another course of treatment for years.

Do we really think a material swathe of the public will eschew this legal, approved, safe version of the drug - and instead opt for a black-market formulation which, by definition, will be sub-standard? How easy would even be to find a compounder willing to do this at that point, knowing they are breaking the law?

I think the impacts of this type of behaviour will be negligible. Not even 1% will go down this route after Zilosul is approved imo. Certainly not in the "US, EU, Canada, Australia" -style marketplaces which make up 70%+ of the global pharma market, and will be the greatest focus for our company.